首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL
被引:18
|
作者
:
SCHAID, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
SCHAID, DJ
[
1
]
INGLE, JN
论文数:
0
引用数:
0
h-index:
0
机构:
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
INGLE, JN
[
1
]
WIEAND, S
论文数:
0
引用数:
0
h-index:
0
机构:
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
WIEAND, S
[
1
]
AHMANN, DL
论文数:
0
引用数:
0
h-index:
0
机构:
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
AHMANN, DL
[
1
]
机构
:
[1]
MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
来源
:
CONTROLLED CLINICAL TRIALS
|
1988年
/ 9卷
/ 02期
关键词
:
D O I
:
10.1016/0197-2456(88)90032-3
中图分类号
:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号
:
1001 ;
摘要
:
引用
收藏
页码:107 / 118
页数:12
相关论文
共 50 条
[21]
CLINICAL-TRIALS FOR ACUTE STROKE THERAPY - PHASE-II VERSUS PHASE-III TRIALS
DIENER, HC
论文数:
0
引用数:
0
h-index:
0
机构:
JANSSEN RES FDN, CLIN RES & DEV, TITUSVILLE, NJ USA
JANSSEN RES FDN, CLIN RES & DEV, TITUSVILLE, NJ USA
DIENER, HC
HANTSON, L
论文数:
0
引用数:
0
h-index:
0
机构:
JANSSEN RES FDN, CLIN RES & DEV, TITUSVILLE, NJ USA
JANSSEN RES FDN, CLIN RES & DEV, TITUSVILLE, NJ USA
HANTSON, L
CEREBROVASCULAR DISEASES,
1995,
5
: 12
-
15
[22]
LOCALLY ADVANCED BREAST-CANCER - REPORT OF PHASE-II STUDY AND SUBSEQUENT PHASE-III TRIAL
RODGER, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
RODGER, A
JACK, WJL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
JACK, WJL
HARDMAN, PDJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
HARDMAN, PDJ
KERR, GR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
KERR, GR
CHETTY, U
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
CHETTY, U
LEONARD, RCF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND
LEONARD, RCF
BRITISH JOURNAL OF CANCER,
1992,
65
(05)
: 761
-
765
[23]
A PHASE-II CLINICAL-TRIAL OF CARBOPLATIN IN ADVANCED OVARIAN-CANCER
POHL, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,DEPT GYNECOL ONCOL,D-7800 FREIBURG,FED REP GER
UNIV FREIBURG,DEPT GYNECOL ONCOL,D-7800 FREIBURG,FED REP GER
POHL, J
MEERPOHL, HG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,DEPT GYNECOL ONCOL,D-7800 FREIBURG,FED REP GER
UNIV FREIBURG,DEPT GYNECOL ONCOL,D-7800 FREIBURG,FED REP GER
MEERPOHL, HG
PFLEIDERER, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV FREIBURG,DEPT GYNECOL ONCOL,D-7800 FREIBURG,FED REP GER
UNIV FREIBURG,DEPT GYNECOL ONCOL,D-7800 FREIBURG,FED REP GER
PFLEIDERER, A
INVESTIGATIONAL NEW DRUGS,
1987,
5
(01)
: 61
-
61
[24]
A SUMMARY OF CLINICAL PHASE-II AND PHASE-III STUDY RESULTS ON OFLOXACIN (HOE-280) IN EUROPE
BLOMER, R
论文数:
0
引用数:
0
h-index:
0
BLOMER, R
BRUCH, K
论文数:
0
引用数:
0
h-index:
0
BRUCH, K
ZAHLTEN, RN
论文数:
0
引用数:
0
h-index:
0
ZAHLTEN, RN
INFECTION,
1986,
14
: S102
-
S107
[25]
METASTATIC PROSTATE-CANCER - PHASE-II CLINICAL-TRIAL OF SPIROGERMANIUM
BUI, NB
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
BUI, NB
CHAUVERGNE, J
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
CHAUVERGNE, J
BRUNET, R
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
BRUNET, R
RICHAUD, P
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
RICHAUD, P
HOERNI, B
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOERNI, B
LAGARDE, C
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
LAGARDE, C
LEGUILLOU, M
论文数:
0
引用数:
0
h-index:
0
机构:
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
HOP PELLEGRIN,SERV UROL,F-33076 BORDEAUX,FRANCE
LEGUILLOU, M
BULLETIN DU CANCER,
1986,
73
(01)
: 65
-
67
[26]
PHASE-II AND PHASE-III STUDIES WITH CARBOPLATIN (JM8, CBDCA)
CALVERT, AH
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
CALVERT, AH
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
WILTSHAW, E
BAKER, JW
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
BAKER, JW
SMITH, IE
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND
SMITH, IE
INVESTIGATIONAL NEW DRUGS,
1984,
2
(01)
: 105
-
105
[27]
CARBOPLATIN AND IFOSFAMIDE IN OVARIAN-CANCER PHASE-II AND PHASE-III TRIALS
WILTSHAW, E
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hospital, London, SW3, 6JJ, Fulham Road
WILTSHAW, E
PERREN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hospital, London, SW3, 6JJ, Fulham Road
PERREN, TJ
FRYATT, ID
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hospital, London, SW3, 6JJ, Fulham Road
FRYATT, ID
BLAKE, PR
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hospital, London, SW3, 6JJ, Fulham Road
BLAKE, PR
HARPER, P
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hospital, London, SW3, 6JJ, Fulham Road
HARPER, P
SLEVIN, M
论文数:
0
引用数:
0
h-index:
0
机构:
Royal Marsden Hospital, London, SW3, 6JJ, Fulham Road
SLEVIN, M
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1990,
26
: S48
-
S50
[28]
PHASE-III CLINICAL-TRIAL WITH NORPLANT(R)-II (2 COVERED RODS) - REPORT ON 5 YEARS OF USE
BUCKSHEE, K
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
BUCKSHEE, K
CHATTERJEE, P
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
CHATTERJEE, P
DHALL, GI
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
DHALL, GI
HAZRA, MN
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
HAZRA, MN
KODKANY, BS
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
KODKANY, BS
LALITHA, K
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
LALITHA, K
LOGAMBAL, A
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
LOGAMBAL, A
MANCHANDA, P
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
MANCHANDA, P
NANDA, UK
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
NANDA, UK
CHOUDHURY, GR
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
CHOUDHURY, GR
RAJARAM, P
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
RAJARAM, P
SENGUPTA, PC
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
SENGUPTA, PC
SIVARAMAN, R
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
SIVARAMAN, R
SUTARIA, UD
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
SUTARIA, UD
ZAVERI, K
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
ZAVERI, K
DATEY, S
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
DATEY, S
GAUR, LN
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
GAUR, LN
GUPTA, NK
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
GUPTA, NK
MENTA, S
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
MENTA, S
ROY, M
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
ROY, M
SAXENA, NC
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
SAXENA, NC
YADAV, SC
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
YADAV, SC
VISHWANATH, P
论文数:
0
引用数:
0
h-index:
0
机构:
RG KAR MED COLL,CALCUTTA,INDIA
VISHWANATH, P
CONTRACEPTION,
1993,
48
(02)
: 120
-
132
[29]
LIPOSOMAL AMPHOTERICIN-B (AMBISOME) - SAFETY DATA FROM A PHASE-II/III CLINICAL-TRIAL
MEUNIER, F
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL FREE HOSP,LONDON,ENGLAND
MEUNIER, F
PRENTICE, HG
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL FREE HOSP,LONDON,ENGLAND
PRENTICE, HG
RINGDEN, O
论文数:
0
引用数:
0
h-index:
0
机构:
ROYAL FREE HOSP,LONDON,ENGLAND
RINGDEN, O
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,
1991,
28
: 83
-
91
[30]
TREATMENT OF HIGH-GRADE NON-HODGKIN LYMPHOMA - RESULTS OF A PHASE-II AND A PHASE-III TRIAL
KOPPLER, H
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
KOPPLER, H
PFLUGER, KH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
PFLUGER, KH
HAVEMANN, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
HAVEMANN, K
ESCHENBACH, I
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
ESCHENBACH, I
PFAB, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
PFAB, R
LENNERT, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
LENNERT, K
WELLENS, W
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
WELLENS, W
论文数:
引用数:
h-index:
机构:
SCHMIDT, M
GASSEL, WD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
GASSEL, WD
KOLB, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
KOLB, R
HASSLER, R
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
HASSLER, R
SCHUMACHER, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
SCHUMACHER, K
VONSPETH, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
VONSPETH, G
GROPP, C
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
GROPP, C
HIRSCHMANN, WD
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
HIRSCHMANN, WD
GOSSMANN, HH
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
GOSSMANN, HH
OHL, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
OHL, S
DRINGS, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
DRINGS, P
HOSSFELD, DK
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
HOSSFELD, DK
BRUNTSCH, U
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
UNIV MARBURG,ZENTRUM INNERE MED,HAMATOL ONKOL ABT,D-3550 MARBURG,FED REP GER
BRUNTSCH, U
BLUT,
1988,
57
(04):
: 220
-
220
←
1
2
3
4
5
→